Prevalence and risk factors of intimate partner violence among pregnant women: a systematic review and meta-analysis

The 2025 systematic review and meta-analysis below, examined 36,214 pregnant women across 37 studies to better understand the prevalence and risk factors of intimate partner

Intimate Partner Violence and Pregnancy and Infant Health Outcomes — Pregnancy Risk Assessment Monitoring System, Nine U.S. Jurisdictions, 2016–2022

Steele-Baser M, Brown AL, D’Angelo DV, et al. Intimate Partner Violence and Pregnancy and Infant Health Outcomes — Pregnancy Risk Assessment Monitoring System, Nine U.S.

Intimate partner violence is a significant risk factor for adverse pregnancy outcomes

Elizabeth P LOCKINGTON MD , Helen C. SHERRELL FRANZCOG, PhD , Kylie CRAWFORD FANZCVS, PhD , Kym RAE PhD , Sailesh KUMAR FRCS, FRCOG, FRANZCOG

Rapid Review on COVID-19, Substance Use, and Intimate Partner Violence

This year, with funding support from the CIHR’s COVID-19 and Mental Health Initiative, the Centre of Excellence for Women’s Health partnered with the Canadian Centre on Substance

CCSA: Action on Intimate Partner Violence and Substance Use

(Email communication from the Canadian Centre on Substance Use and Addiction) Dear colleague, Women are experiencing increased rates of intimate partner violence during the COVID-19 pandemic.

Gender-informed Virtual Interventions Addressing Substance Use and Intimate Partner Violence

CPHA presented a webinar on 20 January 2021 entitled ‘Gender-Informed Virtual Interventions Addressing Substance Use and Intimate Partner Violence’. This webinar described technology-based approaches in

1 2